LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 58 filers reported holding LOGICBIO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $34,000 | -89.1% | 50,285 | -62.8% | 0.00% | – |
Q4 2021 | $312,000 | +40.5% | 135,027 | +178.1% | 0.00% | – |
Q3 2021 | $222,000 | -47.0% | 48,559 | -48.5% | 0.00% | – |
Q2 2021 | $419,000 | -7.1% | 94,314 | +59.5% | 0.00% | – |
Q4 2020 | $451,000 | +219.9% | 59,132 | +279.6% | 0.00% | – |
Q3 2020 | $141,000 | – | 15,578 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |